Patents by Inventor Allan Petersen
Allan Petersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230357452Abstract: Disclosed herein is a sphingan oligosaccharide composition, its uses, and a process for preparing the same.Type: ApplicationFiled: June 29, 2023Publication date: November 9, 2023Applicant: CP KELCO U.S., INC.Inventors: Bastian Borum Andersen, Justin Bradford Thompson, Jan Larsen, Sune Allan Petersen, Lan Ma, Willis C. Baldwin, Jr., JeRay Jay Rosas, Andrew John Ryder
-
Patent number: 11732059Abstract: Disclosed herein is a sphingan oligosaccharide composition, its uses, and a process for preparing the same.Type: GrantFiled: July 15, 2021Date of Patent: August 22, 2023Assignee: CP Kelco U.S., Inc.Inventors: Bastian Borum Andersen, Justin Bradford Thompson, Jan Larsen, Sune Allan Petersen, Lan Ma, Willis C. Baldwin, Jr., JeRay Jay Rosas, Andrew John Ryder
-
Publication number: 20220017649Abstract: Disclosed herein is a sphingan oligosaccharide composition, its uses, and a process for preparing the same.Type: ApplicationFiled: July 15, 2021Publication date: January 20, 2022Applicant: CP KELCO U.S., INC.Inventors: Bastian Borum Andersen, Justin Bradford Thompson, Jan Larsen, Sune Allan Petersen, Lan Ma, Willis C. Baldwin, JR., JeRay Jay Rosas, Andrew John Ryder
-
Patent number: 11207269Abstract: The present invention relates to medical use of liposomes, more particular the first medical use of sPLA2 hydrolysable liposomes. Such liposomes may be used for targeted delivery of therapeutic agents to cancerous tissue and in such embodiments; the therapeutic agents are typically small molecule antitumor agents. Other aspects of the inventions relates to methods of reducing the side effects of therapeutic agents, e.g. reducing nephrotoxicity, neurotoxicity and gastrointestinal toxicity of a therapeutic agent. Yet another aspect of the present invention relate to methods of prolonging the therapeutic effect of a therapeutic agent.Type: GrantFiled: March 21, 2019Date of Patent: December 28, 2021Assignee: BIO-BEDST APSInventors: Morten Just Petersen, Fredrik Melander, Anders Falk Vikbjerg, Sune Allan Petersen, Mogens Winkel Madsen
-
Patent number: 11173178Abstract: The present invention provides liposomes that are useful for delivery of bioactive agents such as therapeutics. Among others, the liposomes of the invention are capable of delivering their payload at sites of increased secretory phospholipase A2 (sPLA2) activity, because phospholipase A2 (PLA2) will hydrolyse lipids of the liposome. Thus, the liposomes of the invention may e.g. be used in relation to cancer therapy. Another aspect of the invention is a liposomal formulation comprising the liposome of the invention. Still another aspect is a method of producing a liposomal formulation of the invention.Type: GrantFiled: February 10, 2020Date of Patent: November 16, 2021Assignee: LiPlasome Pharma ApSInventors: Anders Falk Vikbjerg, Sune Allan Petersen, Fredrik Melander, Jonas Rosager Henriksen, Kent Jørgensen
-
Publication number: 20200171080Abstract: The present invention provides liposomes that are useful for delivery of bioactive agents such as therapeutics. Among others, the liposomes of the invention are capable of delivering their payload at sites of increased secretory phospholipase A2 (sPLA2) activity, because phospholipase A2 (PLA2) will hydrolyse lipids of the liposome. Thus, the liposomes of the invention may e.g. be used in relation to cancer therapy. Another aspect of the invention is a liposomal formulation comprising the liposome of the invention. Still another aspect is a method of producing a liposomal formulation of the invention.Type: ApplicationFiled: February 10, 2020Publication date: June 4, 2020Inventors: Anders Falk VIKBJERG, Sune Allan PETERSEN, Fredrik MELANDER, Jonas Rosager HENRIKSEN, Kent JØRGENSEN
-
Publication number: 20190343766Abstract: The present invention relates to medical use of liposomes, more particular the first medical use of sPLA2 hydrolysable liposomes. Such liposomes may be used for targeted delivery of therapeutic agents to cancerous tissue and in such embodiments; the therapeutic agents are typically small molecule antitumor agents. Other aspects of the inventions relates to methods of reducing the side effects of therapeutic agents, e.g. reducing nephrotoxicity, neurotoxicity and gastrointestinal toxicity of a therapeutic agent. Yet another aspect of the present invention relate to methods of prolonging the therapeutic effect of a therapeutic agent.Type: ApplicationFiled: March 21, 2019Publication date: November 14, 2019Inventors: Morten Just PETERSEN, Fredrik MELANDER, Anders Falk VIKBJERG, Sune Allan PETERSEN, Mogens Winkel MADSEN
-
Patent number: 9820941Abstract: The present invention provides a composition comprising a sPLA2 hydrolysable liposome, an exterior solution, and an interior solution within the liposome, —wherein the concentration of osmolytes is higher in the interior solution than in the exterior solution. The composition improves storage stability of sPLA2 hydrolysable liposomes, in particular at when stored at 2-8 degrees Celsius. The liposome preferably encapsulates cisplatin. The invention also provides methods of preparing the composition of the invention.Type: GrantFiled: October 25, 2010Date of Patent: November 21, 2017Assignee: Bio-Bedst ApSInventors: Mogens Winkel Madsen, Sune Allan Petersen, Anders Falk Vikbjerg
-
Publication number: 20120219618Abstract: The present invention provides a composition comprising a sPLA2 hydrolysable liposome, an exterior solution, and an interior solution within the liposome, -wherein the concentration of osmolytes is higher in the interior solution than in the exterior solution. The composition improves storage stability of sPLA2 hydrolysable liposomes, in particular at when stored at 2-8 degrees Celsius. The liposome preferably encapsulates cisplatin. The invention also provides methods of preparing the composition of the invention.Type: ApplicationFiled: October 25, 2010Publication date: August 30, 2012Applicant: Bio-Bedst ApSInventors: Mogens Winkel Madsen, Sune Allan Petersen, Anders Falk Vikbjerg
-
Publication number: 20120190831Abstract: Methods are provided for high temperature and short time extraction of pectins from pectin-containing plant materials. Generally described, the method includes mixing the pectin-containing plant material and an acidic aqueous medium to form a mixture; heating the mixture (optionally under pressure) to a target temperature by steam injection; maintaining the mixture under pressure at the target temperature for a time up to about 5 minutes; and flashing the mixture into a flash tank at a pressure from about 0.5 to about 1.2 bar to extract pectin from the pectin-containing plant material.Type: ApplicationFiled: January 25, 2011Publication date: July 26, 2012Applicant: CP KELCO APSInventors: Brian Rudolph, Sune Allan Petersen
-
Publication number: 20120009243Abstract: The present invention provides liposomes that are useful for delivery of bioactive agents such as therapeutics. Among others, the liposomes of the invention are capable of delivering their payload at sites of increased secretory phospholipase A2 (sPLA2) activity, because phospholipase A2 (PLA2) will hydrolyse lipids of the liposome. Thus, the liposomes of the invention may e.g. be used in relation to cancer therapy. Another aspect of the invention is a liposomal formulation comprising the liposome of the invention. Still another aspect is a method of producing a liposomal formulation of the invention.Type: ApplicationFiled: May 25, 2009Publication date: January 12, 2012Applicant: LIPLASOME PHARMA APSInventors: Anders Falk Vikbjerg, Sune Allan Petersen, Fredrik Melander, Jonas Rosager Henriksen, Kent Jørgensen
-
Publication number: 20050209546Abstract: A remote control sub-system for use in controlling a fluid circuit wherein the fluid circuit includes at least one tubing segment which is operatively engaged with a flow control device such as a pump so that the pump is operable to force fluid to flow in and through the tubing segment. The remote control sub-system has a remote control device with a switching member operatively connected thereto; the remote control device being disjoined from the flow control device yet being disposed in operative communication therewith such that activation of the switching member is effective to turn on or off the flow control device to start or stop the flow of fluid through the tubing segment.Type: ApplicationFiled: July 29, 2004Publication date: September 22, 2005Applicant: Gambro Lundia ABInventors: Jorgen Jonsson, Allan Petersen
-
Publication number: 20010007058Abstract: A remote control sub-system for use in controlling a fluid circuit wherein the fluid circuit includes at least one tubing segment which is operatively engaged with a flow control device such as a pump so that the pump is operable to force fluid to flow in and through the tubing segment. The remote control sub-system has a remote control device with a switching member operatively connected thereto; the remote control device being disjoined from the flow control device yet being disposed in operative communication therewith such that activation of the switching member is effective to turn on or off the flow control device to start or stop the flow of fluid through the tubing segment.Type: ApplicationFiled: December 13, 2000Publication date: July 5, 2001Inventors: Jorgen Jonsson, Allan Petersen
-
Patent number: 5227049Abstract: A blood treatment apparatus having a circuit for circulating blood outside the body and designed to be connected to a patient via a single needle, including a blood treatment device such as a heamodialyzer, pumps for causing blood to flow through the circuit, a first blood expansion chamber located in the circuit upstream of the blood treatment device for temporarily storing a volume of blood to be treated, a second blood expansion chamber located downstream of the blood treatment device for temporarily storing a volume of treated blood, first and second pressure regulators, connected to the first and second blood expansion chambers, for adjusting pressure in the blood expansion chambers, and a controller for interacting with the regulators to maintain a substantially constant pressure in each of the first and second chambers during a treatment session.Type: GrantFiled: August 9, 1991Date of Patent: July 13, 1993Assignee: Hospal IndustrieInventors: Jacques Chevallet, Jean-Claude Riquier, Carl-Henry rndal, Allan Petersen